Drugs / MaaT011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02928523 | Jun 2016 → Aug 2017 | acute myeloid leukemia | MaaT Pharma | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MaaT011 | “Patients will receive autologous fecal microbiota transplantation (MaaT011- 150 mL rectal enema) - 2 administrations 24 hours apart.” NCT02928523 ↗ |
| Action | Restore | “restore the balance of their intestinal microbiome” NCT02928523 ↗ |
| Route | Rectal | “150 mL rectal enema” NCT02928523 ↗ |